Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 1/20 | 0.40 |
| ▸ | FGF1 | P05230 | 2/20 | 0.39 |
| ▸ | FGF2 | P09038 | 2/20 | 0.39 |
| ▸ | VEGFA | P15692 | 2/20 | 0.39 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.39 |
| ▸ | NT5E | P21589 | 1/20 | 0.39 |
| ▸ | SELP | P16109 | 5/20 | 0.38 |
| ▸ | SELE | P16581 | 1/20 | 0.37 |
| ▸ | SYNJ2 | O15056 | 3/20 | 0.36 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.36 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.36 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.36 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15965621 | 0.91 | LGALS3 (0.45) | FGF1FGF2VEGFAHPSESELP | |
| SCHEMBL15965629 | 0.90 | POLB (0.41) | TYMPFGF1FGF2VEGFAHPSE | |
| SCHEMBL4402915 | 0.88 | FGF1 (0.39) | TYMPFGF1FGF2VEGFAHPSE | |
| SCHEMBL4402910 | 0.87 | FGF2 (0.41) | TYMPFGF1FGF2VEGFAHPSE | |
| SCHEMBL15965615 | 0.87 | NT5E (0.39) | FGF1FGF2VEGFAHPSENT5E | |
| SCHEMBL14683530 | 0.87 | LGALS3 (0.45) | TYMPFGF1FGF2VEGFAHPSE | |
| SCHEMBL4403642 | 0.85 | FGF1 (0.38) | FGF1FGF2VEGFAHPSENT5E | |
| SCHEMBL4407362 | 0.85 | FGF2 (0.40) | FGF1FGF2VEGFAHPSENT5E | |
| SCHEMBL8579524 | 0.84 | NT5E (0.43) | FGF1FGF2VEGFAHPSENT5E | |
| SCHEMBL15965614 | 0.83 | POLB (0.46) | FGF2KMT2AMEN1USP2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140235850-A1 | SYNTHESIS OF HMO CORE STRUCTURES | GLYCOM A/S (DK) | 2014-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140235850-A1 | SYNTHESIS OF HMO CORE STRUCTURES | GNE, OGT, GALE | TYMP 281/4885FGF1 3824/4885FGF2 3797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.